Hemic & Lymphatic

DC 7723

Acquired hemolytic anemia

Educational use only. Not legal or medical advice. Read 38 CFR §4.117 on eCFR
Diagnostic Code
7723
CFR Section
§4.117 — Hemic & Lymphatic

Rating Tiers

100%

Requiring a bone marrow transplant or continuous intravenous or immunosuppressive therapy (e.g., prednisone, Cytoxan, azathioprine, or rituximab)

60%

Requiring immunosuppressive medication 4 or more times per 12-month period

30%

Requiring at least 2 but less than 4 courses of immunosuppressive therapy per 12-month period

10%

Requiring one course of immunosuppressive therapy per 12-month period

What Raters Look For

Based on M21-1 adjudication criteria for Hemic & Lymphatic conditions. These are the factors a VA rater evaluates when assigning a rating percentage.

M21-1 III.iv.4.G
  • •Complete blood count (CBC) values: hemoglobin, platelet count, white cell count
  • •Whether transfusions are required and how frequently
  • •Bone marrow biopsy or transplant history
  • •Response to treatment and current treatment regimen
  • •Constitutional symptoms: fatigue, weight loss, fever